Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · Executive Chairman | January 02, 2026 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 238,462 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Tax withholding · Disposed 2,171 · Balance 238,462 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 26, 2023 Filed Dec 29, 2023 01:19 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 80,000 | $3.95 | $316,360.00 |
DisclosureSEC source: 0001551306-23-000118 · wk-form4_1703812740.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2023 Filed Dec 22, 2023 21:40 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-23-000117 · wk-form4_1703281206.xml · derivative · entry 9 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,706,053 Underlying: Common Stock · 80,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| December 22, 2023 Filed Dec 22, 2023 21:40 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 80,000 | $38.11 | $3,048,408.00 |
DisclosureSEC source: 0001551306-23-000117 · wk-form4_1703281206.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,439 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $38.39 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 22, 2023 Filed Dec 22, 2023 21:40 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 80,000 | $3.95 | $316,360.00 |
DisclosureSEC source: 0001551306-23-000117 · wk-form4_1703281206.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2023 Filed Dec 22, 2023 21:40 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-23-000117 · wk-form4_1703281206.xml · derivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,786,053 Underlying: Common Stock · 80,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| December 21, 2023 Filed Dec 22, 2023 21:40 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 80,000 | $37.65 | $3,011,952.00 |
DisclosureSEC source: 0001551306-23-000117 · wk-form4_1703281206.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,439 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 21, 2023 Filed Dec 22, 2023 21:40 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 80,000 | $3.95 | $316,360.00 |
DisclosureSEC source: 0001551306-23-000117 · wk-form4_1703281206.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 21:40 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,906 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-23-000117 · wk-form4_1703281206.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,866,053 Underlying: Common Stock · 2,906 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 21:40 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,906 | $37.50 | $108,986.91 |
DisclosureSEC source: 0001551306-23-000117 · wk-form4_1703281206.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,439 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.53 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 21:40 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 2,906 | $3.95 | $11,491.78 |
DisclosureSEC source: 0001551306-23-000117 · wk-form4_1703281206.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2023 Filed Dec 19, 2023 00:39 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,063 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001551306-23-000116 · wk-form4_1702946348.xml · derivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,868,959 Underlying: Common Stock · 1,063 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| December 14, 2023 Filed Dec 19, 2023 00:39 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,063 | $37.53 | $39,894.39 |
DisclosureSEC source: 0001551306-23-000116 · wk-form4_1702946348.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,439 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 14, 2023 Filed Dec 19, 2023 00:39 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 1,063 | $3.95 | $4,203.63 |
DisclosureSEC source: 0001551306-23-000116 · wk-form4_1702946348.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Due to a clerical error in the initial report of this option grant, the conversion price is being updated to reflect the true and accurate conversion price on the date of grant. This error was recently discovered as this is the first exercise of options under this grant for the Reporting Person. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 19:55 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 21,186 | $32.20 | $682,189.20 |
DisclosureSEC source: 0001551306-23-000099 · wk-form4_1700682916.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,439 F2 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 19:55 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 41,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001551306-23-000099 · wk-form4_1700682916.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,625 F1 · shares: Performance-vested restricted stock units ("PSUs") that were earned pursuant to the terms of a PSU award granted on January 1, 2022 ("Award"). Each PSU became vested on October 31, 2023 the date the Compensation Committee certified the achievement of the applicable performance objectives in accordance with the Award. Pursuant to terms of the Award, each PSU entitled the filer to receive one share of common stock for each PSU. The vested shares were settled on November 20, 2023, after the Issuer's trading blackout period ended and trading was permitted to commence. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 23:13 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 2,681 | $34.02 | $91,207.62 |
DisclosureSEC source: 0001551306-23-000079 · wk-form4_1696461198.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,125 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| July 13, 2023 Filed Jul 14, 2023 20:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 67,457 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-024915 · wf-form4_168936491314322.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 232,228 Underlying: Common Stock · 67,457 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| July 13, 2023 Filed Jul 14, 2023 20:02 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 67,457 | $38.95 | $2,627,450.15 |
DisclosureSEC source: 0001628280-23-024915 · wf-form4_168936491314322.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,806 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.67 to $39.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 13, 2023 Filed Jul 14, 2023 20:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 67,457 | $0.91 | $61,385.87 |
DisclosureSEC source: 0001628280-23-024915 · wf-form4_168936491314322.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 20:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,687 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-024915 · wf-form4_168936491314322.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 299,685 Underlying: Common Stock · 38,687 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 20:02 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 38,687 | $38.64 | $1,494,865.68 |
DisclosureSEC source: 0001628280-23-024915 · wf-form4_168936491314322.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,806 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.63 to $38.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 20:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 38,687 | $0.91 | $35,205.17 |
DisclosureSEC source: 0001628280-23-024915 · wf-form4_168936491314322.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2023 Filed Jul 7, 2023 21:15 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 2,681 | $39.34 | $105,470.54 |
DisclosureSEC source: 0001628280-23-024569 · wf-form4_168876448869373.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,806 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 18,856 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-024448 · wf-form4_168867373131535.xml · derivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 338,372 Underlying: Common Stock · 18,856 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:02 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 18,856 | $38.76 | $730,858.56 |
DisclosureSEC source: 0001628280-23-024448 · wf-form4_168867373131535.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,487 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.56 to $39.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 18,856 | $0.91 | $17,158.96 |
DisclosureSEC source: 0001628280-23-024448 · wf-form4_168867373131535.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:23 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 41,666 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-021338 · wf-form4_168617661378230.xml · derivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 357,228 Underlying: Common Stock · 41,666 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:23 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 32,136 | $40.24 | $1,293,152.64 |
DisclosureSEC source: 0001628280-23-021338 · wf-form4_168617661378230.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,487 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.76 to $40.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:23 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 9,530 | $39.21 | $373,671.30 |
DisclosureSEC source: 0001628280-23-021338 · wf-form4_168617661378230.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,623 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.64 to $39.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:23 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 41,666 | $0.91 | $37,916.06 |
DisclosureSEC source: 0001628280-23-021338 · wf-form4_168617661378230.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 20:48 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 41,667 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-020893 · wf-form4_168599812233509.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 398,894 Underlying: Common Stock · 41,667 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 20:48 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 41,667 | $38.68 | $1,611,679.56 |
DisclosureSEC source: 0001628280-23-020893 · wf-form4_168599812233509.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,487 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.09 to $39.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 20:48 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 41,667 | $0.91 | $37,916.97 |
DisclosureSEC source: 0001628280-23-020893 · wf-form4_168599812233509.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:48 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 41,667 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-020893 · wf-form4_168599812233509.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 440,561 Underlying: Common Stock · 41,667 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:48 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 20,919 | $37.80 | $790,738.20 |
DisclosureSEC source: 0001628280-23-020893 · wf-form4_168599812233509.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,487 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.66 to $37.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:48 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 20,748 | $37.29 | $773,692.92 |
DisclosureSEC source: 0001628280-23-020893 · wf-form4_168599812233509.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,406 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.65 to $37.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:48 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 41,667 | $0.91 | $37,916.97 |
DisclosureSEC source: 0001628280-23-020893 · wf-form4_168599812233509.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 34,593 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-017909 · wf-form4_168392293745600.xml · derivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 482,228 Underlying: Common Stock · 34,593 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,019 | $38.43 | $77,590.17 |
DisclosureSEC source: 0001628280-23-017909 · wf-form4_168392293745600.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,487 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.25 to $38.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 32,574 | $37.68 | $1,227,388.32 |
DisclosureSEC source: 0001628280-23-017909 · wf-form4_168392293745600.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,506 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.25 to $38.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 34,593 | $0.91 | $31,479.63 |
DisclosureSEC source: 0001628280-23-017909 · wf-form4_168392293745600.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-017252 · wf-form4_168375027178997.xml · derivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 516,821 Underlying: Common Stock · 100,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 19,490 | $38.25 | $745,492.50 |
DisclosureSEC source: 0001628280-23-017252 · wf-form4_168375027178997.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,487 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $38.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 73,485 | $37.61 | $2,763,770.85 |
DisclosureSEC source: 0001628280-23-017252 · wf-form4_168375027178997.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,977 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.05 to $38.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 7,025 | $36.85 | $258,871.25 |
DisclosureSEC source: 0001628280-23-017252 · wf-form4_168375027178997.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 166,462 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $37.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 100,000 | $0.91 | $91,000.00 |
DisclosureSEC source: 0001628280-23-017252 · wf-form4_168375027178997.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 173,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 67,887 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-017252 · wf-form4_168375027178997.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 616,821 Underlying: Common Stock · 67,887 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 67,887 | $35.11 | $2,383,512.57 |
DisclosureSEC source: 0001628280-23-017252 · wf-form4_168375027178997.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,487 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 67,887 | $0.91 | $61,777.17 |
DisclosureSEC source: 0001628280-23-017252 · wf-form4_168375027178997.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 20:58 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,224 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-012986 · wf-form4_168245631250830.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 684,708 Underlying: Common Stock · 10,224 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.